Results 61 to 70 of about 1,471,694 (149)

Cytoreductive surgery and HIPEC in the treatment of peritoneal metastases of sarcomas and other rare malignancies

open access: yes, 2017
..................................... Cytoreductive surgery and HIPEC in the treatment of peritoneal metastases of sarcomas and other rare malignancies.
Tomasz Olesiński
core   +1 more source

Epidemiological and Prognostic Differences in Malignant Mesothelioma Between Eastern China and SEER Database

open access: yesCancer Science, EarlyView.
For long years, patients and clinicians in Eastern China used Western data as information foundation for management and treatment of malignant mesothelioma, due to its rarity and lack of deep investigation. This study updated the epidemiological data of malignant mesothelioma in Eastern China, and revealed better survival outcomes compared to Western ...
Ningning Li   +7 more
wiley   +1 more source

Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. [PDF]

open access: yes, 2007
OBJECTIVE: This study aims to identify favorable preoperative characteristics and examine the impact of secondary cytoreductive surgery on survival for patients with recurrent epithelial ovarian carcinoma.
Palmer, James M   +5 more
core   +1 more source

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto   +12 more
wiley   +1 more source

Inhibition of P‐glycoprotein using photoimmunotherapy in peritoneal metastasis mouse model

open access: yesPhotochemistry and Photobiology, EarlyView.
Photoimmunotherapy (PIT) using photoimmunoconjugates (PICs) can inhibit the function of the ATP‐binding cassette (ABC) transporter P‐glycoprotein (P‐gp) in a mouse model of peritoneal carcinomatosis. Sterile‐filtered PIC was administered in vivo via intraperitoneal (IP) injection 20 days after IP tumor cell implantation of P‐gp‐overexpressing NCI/ADR ...
Kaitlyn A. Moore   +6 more
wiley   +1 more source

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations

open access: yes, 2019
Laura M Enomoto, Perry Shen, Edward A Levine, Konstantinos I VotanopoulosWake Forest Baptist Medical Center, Medical Center Boulevard, Winston Salem, NC 27157, USAAbstract: Malignant peritoneal mesothelioma (MPM) is a rare, aggressive malignancy that ...
Enomoto LM   +3 more
core  

Cytoreductive Surgery for recurrent epithelial ovarian cancer

open access: yes
We aim to evaluate the benefits and hamrs of secondary cytoreductive surgery plus chemotherapy versus chemotherapy alone for women with recurrent epithelial ovarian ...
Ashraf Nabhan
core   +1 more source

Cytoreductive surgery for advanced-stage ovarian cancer

open access: yes, 2012
Usually, ovarian cancer develops asymptomatically. Nearly 30%-40% of the newly-diagnosed cases are already at III-IV stage of FIGO. In such patients, there are metastases on the peritoneum of the whole abdominal cavity.
Slavchev, Stanislav; Medical University of Varna   +1 more
core   +1 more source

The impact of extensive cytoreductive surgery for ovarian cancer on the histopathology laboratory workload [PDF]

open access: yes, 2017
Objectives: Cytoreductive surgery is the principal management for ovarian cancer. Recently there has been progressive change to more extensive cytoreductive surgery (ECS) as evidence shows this improves patient prognosis. The aim of this
Mona El Bahrawy   +3 more
core   +1 more source

Clinical Behaviour and Outcome of Pelvic Osteosarcoma in Dogs: A Retrospective Multicentre Analysis of 74 Cases (2007–2025)

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Although osteosarcoma is the most common primary bone tumour in dogs, involvement of the pelvic bones is rare. The aim of the present study was to describe clinical presentation, identify possible prognostic factors, and evaluate outcomes in dogs diagnosed with pelvic osteosarcoma.
Csilla Fejös   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy